Cannabinoid receptor 1 (CB1) is a promising drug target involved in many physiological processes. Using atomistic molecular dynamics (MD) simulations, we examined the structural effect of F237L mutation on CB1, a mutation that has qualitatively similar effects to allosteric ligand ORG27569 binding. This mutation showed a global effect on CB1 conformations. Among the observed effects, TM6 outward movement and the conformational change of the NPxxY motif upon receptor activation by CB1 agonist CP55940 were hindered compared to wt CB1. Within the orthosteric binding site, CP55940 interactions with CB1 were altered. Our results revealed that allosteric perturbations introduced by the mutation had a global impact on receptor conformations, sugge...
There is considerable interest in determining the activation mechanism of G protein-coupled receptor...
The recent resolution of the crystal structure of type-1 cannabinoid receptor (CB1 ), and the discov...
A Cannabinoid Receptor 1 (CB1) binding site for the selective allosteric modulator ORG27569 is here ...
The endocannabinoid system has been historically targeted for medicinal purposes through the use of ...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
Positive allosteric modulation of the cannabinoid 1 receptor (CB1R) has demonstrated distinct therap...
During this study the [35S]GTPγS binding, equilibrium binding and dissociation kinetic assays were u...
The endocannabinoid system has been historically targeted for medicinal purposes through the use of ...
The human cannabinoid-1 (CB1) receptor is a Class A, rhodopsin-like G protein-coupled receptor (GPCR...
The type I cannabinoid G protein-coupled receptor (CB1, GPCR) is an intensely investigated pharmacol...
Molecular dynamic (MD) simulations have become a common tool to study the pathway of ligand entry to...
Selective activation of the cannabinoid receptor subtype 2 (CB2) shows promise for treating pain, in...
Computational studies to determine the binding site of ORG27569, a negative allosteric modulator, wi...
There is considerable interest in determining the activation mechanism of G protein-coupled receptor...
The recent resolution of the crystal structure of type-1 cannabinoid receptor (CB1 ), and the discov...
A Cannabinoid Receptor 1 (CB1) binding site for the selective allosteric modulator ORG27569 is here ...
The endocannabinoid system has been historically targeted for medicinal purposes through the use of ...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
Positive allosteric modulation of the cannabinoid 1 receptor (CB1R) has demonstrated distinct therap...
During this study the [35S]GTPγS binding, equilibrium binding and dissociation kinetic assays were u...
The endocannabinoid system has been historically targeted for medicinal purposes through the use of ...
The human cannabinoid-1 (CB1) receptor is a Class A, rhodopsin-like G protein-coupled receptor (GPCR...
The type I cannabinoid G protein-coupled receptor (CB1, GPCR) is an intensely investigated pharmacol...
Molecular dynamic (MD) simulations have become a common tool to study the pathway of ligand entry to...
Selective activation of the cannabinoid receptor subtype 2 (CB2) shows promise for treating pain, in...
Computational studies to determine the binding site of ORG27569, a negative allosteric modulator, wi...
There is considerable interest in determining the activation mechanism of G protein-coupled receptor...
The recent resolution of the crystal structure of type-1 cannabinoid receptor (CB1 ), and the discov...
A Cannabinoid Receptor 1 (CB1) binding site for the selective allosteric modulator ORG27569 is here ...